Eykona Technologies will meet a substantial and recognised unmet need in the objective measurement and characterisation of hard-to-heal wounds such as diabetic ulcers. The company will do this using a patented 3D medical imaging device based on cutting edge technology developed in the University of Oxford. The company will initially enter this market in Europe and the USA. The product consists of a proprietary camera and software package. Eykona will make its product the gold standard for clinical assessment and characterisation of wounds. The product can also be used in other clinical areas, such as cosmetics and dermatology, where dermal imaging can deliver significant benefits.

Current commercial status

Eykona Technologies has developed pre-production prototype systems comprising hardware and software, and is engaged in clinical evaluations at key diabetic centres in the UK.  Clinical evaluations in the US are imminent. Eykona has secured two early investment rounds and is currently building a series A round to take the company through to and beyond launch.